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1. Background Information: 
 
       Hypoplastic left heart syndrome (HLHS) collectively refers to a range of congenital heart 
defects, all involving some degree of left ventricular hypoplasia, or underdevelopment of the left 
ventricle.1,2  Additionally, HLHS often involves coarctation of the aorta,1 and can also include 
hypoplasia of the ascending aorta, as well as mitral and/or aortic valve stenosis or atresia.1,2  
HLHS is extremely rare, as it has been reported to occur in only 1 in 5000 live births each year.2  
The cause of HLHS is currently unknown, however much research is being done to discover how 
and why these defects occur. 
HLHS is known to be familially inherited in some instances and is also associated with 
many well-characterized genetic disorders, including Holt-Oram syndrome, Turner’s syndrome, 
Noonan syndrome, Smith-Lemli-Opitz syndrome, as well as trisomies 13, 18, and 21.1,2 
Additionally, an autosomal recessive pattern of inheritance has been found amongst some 
siblings, however, no specific genes have been implicated.2   Incidence of HLHS also varies 
significantly in certain geographical regions and some studies have found a seasonal correlation 
in HLHS, indicating a possible environmental cause.2,3   
 
2. Hypothesis and Rationale: 
 
A study done in 2011 by 
Eghtesady, et. al. found a moderate 
to strong correlation between 
seasonality and HLHS. 
Interestingly, among the four left-
sided congenital heart defects 
studied at the time, HLHS was the 
only disease that showed such a 
correlation (Figure 2.1).  HLHS 
was found to be more prevalent in 
babies born during the early 
summer months, particularly 
during the month of June.3  If these 
were full-term pregnancies, infants 
born at this time of year would 
have been conceived during the 
fall, around September, right 
when the seasons are 
transitioning. 
 
 
Figure 2.1.  Seasonality of HLHS – incidence of HLHS was 
found to be increased in the summer months, and decreased 
in the winter months.  This seasonal correlation was not 
found with any other left heart defects.  (Adapted from: 
Eghtesady, P., Brar, A., & Hall, M.  Seasonality of hypoplastic left heart 
syndrome in the United States: A 10-year time--series analysis. Journal of 
Thoracic and CV Surgery.  2011; 432-438.) 
During the transition of seasons, symptoms of allergies, or even the common cold, may 
start to form. These symptoms could lead mothers to take medications, such as decongestants, to 
combat these seasonal illnesses. A common over-the-counter medication used is 
pseudoephedrine, also known as Sudafed, a decongestant.  Studies have found that 25% of 
women are exposed to pseudoephedrine during their pregnancy.4 In order to be effective, 
pseudoephedrine acts on the α1 and the β2 receptors found on the walls of the blood vessels. 
When pseudoephedrine binds to these receptors, it initiates the α1 pathway in which the second 
messenger, DAG, activates Protein Kinase C (PKC).  PKC then causes phosphorylation of a 
protein that promotes the constriction of the smooth muscle that makes up blood vessels. When 
this constriction occurs, blood flow is limited.5  
 
 
Figure 2.2. Mechanism of PKC activation by pseudoephedrine via the GQ pathway. 
 
PKC also plays a role in a number of cell signaling pathways including pathways that are 
responsible for controlling expression of some Tbx genes, particularly Tbx2 (Figure 2.2).6  Tbx 
genes code for a family of transcription factors, the T-box proteins, which are crucial for 
determination of cell differentiation in early embryogenesis, including cardiogenesis.  Various T-
box proteins play a role in initial specification of the cardiac mesoderm, regionalization of the 
primitive heart tube into chamber and non-chamber cardium, recruitment of second heart field 
cells, and formation of the valves and septa.7  
Tbx mutations have already been identified as the cause for many other well-
characterized genetic conditions involving congenital heart defects, including some of the 
diseases previously mentioned to be frequently associated with HLHS.  For example, Holt-Oram 
syndrome is caused by a heterozygous mutation in the Tbx5 gene.7  Heterozygous mutation of 
another gene, Tbx1 has been 
implicated as the cause of 
DiGeorge’s syndrome, also 
called 22q11.2 deletion 
syndrome.7,8  Interestingly, 
mosaic 22q11 deletion has also 
been reported in many HLHS 
cases.2 
Evidence has also shown 
that a specific form of HLHS - 
aortic atresia with a hypoplastic 
but perforate mitral valve - is 55-
70% more common in males.2  
This increased prevalence in 
males could indicate a sex-linked 
gene as the cause of that form.  
Tbx22 is found on the X 
chromosome, and its mutation 
has been shown to cause birth 
defects.7  Although no heart 
defects have been associated with 
Tbx22 mutation, based on the 
complex roles T-box proteins 
play in embryogenesis, it is possible that TBX22 still affects cardiogenesis, and ultimately left 
heart development, in some manner.  Additionally, there could be another sex-linked Tbx gene 
that is currently unidentified. 
TBX2 is especially important, as this protein is known to have an effect on other T-box 
proteins.  TBX2 is involved in a pathway that actually represses the activity of TBX1, TBX5, 
and TBX20, thus preventing expression of genes that lead to heart chamber formation (Figure 
3.1).8  It is therefore possible that overexpression of TBX2 can lead to an increase in this 
repressive mechanism.  As mentioned previously, TBX5 and TBX20 are important in left heart 
development and it is therefore likely increased repression of TBX5 and TBX20 will specifically 
cause decreased formation of the left heart and HLHS.   
 
3. Significance and Innovation: 
   
 In order to test this hypothesis, a large scale epidemiological study would need to be done 
that monitors the use of decongestants during pregnancy, and examines any correlations between 
their use and the occurrence of HLHS.  If a correlation between pseudoephedrine usage during 
pregnancy and fetal HLHS was found, medications containing pseudoephedrine would need to 
be more clearly labeled as a possible cause for birth defects. Until definitive studies are done, we 
would strongly discourage pregnant women to take these medications during pregnancy. One 
reason the effects of decongestants on HLHS has not been researched heavily in the past, is 
because pregnant women are typically excluded from clinical trials.6  Therefore, we suggest 
using an animal model to monitor the effects of decongestant use on PKC levels and 
cardiogenesis.  
 
Figure 3.1.  TBX2 represses the activity of TBX1, TBX5, and 
TBX20, leading to decreased expression of chamber 
myocardial genes. 
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